Vibeke Andresen

5PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesRegenerative medicine (incl. stem cells)Haematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 25, 2024
Preclinical activity of resazurin in acute myeloid leukaemia.

Trung Quang Ha, Vibeke Andresen, Bjarte Skoe Erikstein

|Sep 22, 2023
The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?

Brunangelo Falini, Bjorn T Gjertsen, Vibeke Andresen

|Mar 30, 2023
Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia.

Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt

|Jan 07, 2023
Early response evaluation by single cell signaling profiling in acute myeloid leukemia.

Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt

|Dec 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AML.

Jad Othman, Manja Meggendorfer, Enrico Tiacci

Pageof 1